 |
 |
CONTENTS
· Scientific
Agenda
·
Continuing
Medical
Education
·
Who Should
Attend?
·
Objectives
·
Registration
·
Location
· Organizer |
|
This
symposium is made possible by an
unrestricted educational grant from
Boehringer Ingelheim Pharmaceuticals,
Inc.
Boehringer Ingelheim
Pharmaceuticals, Inc. has been assigned
meeting space to support an educational
offering during the 48th Annual
Meeting & Exposition of the
American Society of Hematology (ASH).
The assignment of
meeting space does not imply product
endorsement nor does ASH assume
responsibility for the educational
content.
|
|
|
|
|
| |
| |
| |
|
| |
| |
|
 |
 |
|
 |
 |
|
FRIDAY, DECEMBER 8, 2006
Clinical Challenges and Unmet Needs in Anticoagulant
Therapy
A Satellite Symposium preceding the 48th ASH Annual
Meeting
12:30 pm - 4:00 pm
The Peabody Orlando, Florida Ballroom
Chair:
Jeffrey I. Weitz, MD, FRCP, FACP, FCCP
Click here
to register online |
 |
|
S C I E N T I F I C A G E N D A |
 |
|
| 12:30
pm
Lunch is served
1:15
pm
Welcome and introduction
Jeffrey I. Weitz, MD, FRCP, FACP, FCCP
McMaster University, Ontario, Canada
1:20
pm
Current antithrombotic strategies: Prevention,
treatment, and consequences
Gary E. Raskob, PhD
University of Oklahoma Health Sciences Center,
Oklahoma City, Oklahoma
1:45
pm
Questions and answers
1:50
pm
Challenges in anticoagulation for VTE and
AF: Considerations of risk stratification
and length of therapy
Samuel Z. Goldhaber, MD
Harvard Medical School, Boston, Massachusetts
2:15
pm
Questions and answers
2:20
pm
Emerging approaches to anticoagulation
Jeffrey I. Weitz, MD
2:45
pm
Questions and answers
2:50
pm
Challenging cases and panel discussion
3:45
pm
Closing remarks
Jeffrey I. Weitz, MD |
|
|
|
C O N T I N U I N G M E D I C A L
E D U C A T I O N |
|
|
| 
Imedex®, Inc. is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing
medical education for physicians.
Imedex,
Inc. designates this educational activity
for a maximum of 2.5 category 1 credits
toward the AMA Physician’s Recognition
Award. Each physician should claim only
those credits that he/she actually spent
in the activity. |
|
|
|
W H O S H O U L D A T T E N
D ? |
|
|
| This
activity is aimed at hematologists, cardiologists,
surgeons, and other healthcare professionals
involved in the treatment, prophylaxis and
management of patients at risk for VTE or
stroke. |
|
|
|
O B J E C T I V E S |
|
|
|
After successful completion of this program,
the participant will be able to:
-
Describe the role of anticoagulation as
a standard of care for improving patient
outcomes in VTE and stroke
-
Assess the advantages and disadvantages
of various anticoagulation therapies,
including pharmacologic and pharmacokinetic
properties, based on current clinical
evidence
-
Discuss the integration of emerging antithrombotic
agents into treatment strategies for the
prevention and treatment of venous thrombosis
|
|
|
|
|
R E G I S T R A T I O N |
|
|
| This
is a complimentary educational program and
space is limited. To confirm your attendance,
please register by December 1, 2006. You
may register online
or call Imedex at +1 (770) 751 7332. Registration
confirmations will be issued before the
meeting. |
|
|
|
M E E T I N G L O C A T
I O N |
|
|
| The
Peabody Orlando
9801
International Drive
Orlando, Florida 32819
The Florida Ballroom
|
|
|
|
H O T E L A C
C O M M O D A T I O N S |
|
|
|
Accommodations
are NOT included in the complimentary satellite
symposia registration.
To
register for the 48th Annual ASH Meeting
and Exposition or make hotel reservations,
please refer to the American Society of
Hematology at the following link: http://www.hematology.org/meetings/2006/index.cfm
|
|
|
|
S Y M P O S I U M O R G A
N I Z E R |
|
|
|
| |
|
|
|
| |
|
|
| ©
2006 Imedex®, Inc |
|
|
|
